Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 6940

1.

Immunogenicity and safety of concomitant MF59-adjuvanted influenza vaccine and 23-valent pneumococcal polysaccharide vaccine administration in older adults.

Song JY, Cheong HJ, Tsai TF, Chang HA, Choi MJ, Jeon JH, Kang SH, Jeong EJ, Noh JY, Kim WJ.

Vaccine. 2015 May 14. pii: S0264-410X(15)00617-9. doi: 10.1016/j.vaccine.2015.05.003. [Epub ahead of print]

PMID:
25980426
2.

The UK immunisation schedule: changes to vaccine policy and practice in 2013/14.

Atchison CJ, Hassounah S.

JRSM Open. 2015 May 11;6(4):2054270415577762. doi: 10.1177/2054270415577762. eCollection 2015 Apr. Review.

3.

Flucelvax (Optaflu) for seasonal influenza.

Manini I, Domnich A, Amicizia D, Rossi S, Pozzi T, Gasparini R, Panatto D, Montomoli E.

Expert Rev Vaccines. 2015 May 12:1-16. [Epub ahead of print]

PMID:
25968069
4.

The stimulatory effect of the TLR4-mediated adjuvant glucopyranosyl lipid A is well preserved in old age.

Weinberger B, Joos C, Reed SG, Coler R, Grubeck-Loebenstein B.

Biogerontology. 2015 May 9. [Epub ahead of print]

PMID:
25957253
5.

Influenza vaccines for preventing cardiovascular disease.

Clar C, Oseni Z, Flowers N, Keshtkar-Jahromi M, Rees K.

Cochrane Database Syst Rev. 2015 May 5;5:CD005050. [Epub ahead of print]

PMID:
25940444
6.

Delivery of GM-CSF to Protect against Influenza Pneumonia.

Subramaniam R, Hillberry Z, Chen H, Feng Y, Fletcher K, Neuenschwander P, Shams H.

PLoS One. 2015 Apr 29;10(4):e0124593. doi: 10.1371/journal.pone.0124593. eCollection 2015.

7.

Concurrent and cross-season protection of inactivated influenza vaccine against A(H1N1)pdm09 illness among young children: 2012-2013 case-control evaluation of influenza vaccine effectiveness.

Fu C, Xu J, Lin J, Wang M, Li K, Ge J, Thompson MG.

Vaccine. 2015 Jun 9;33(25):2917-21. doi: 10.1016/j.vaccine.2015.04.063. Epub 2015 Apr 26.

PMID:
25921713
8.

Safety of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled clinical trial among children in urban Bangladesh.

Ortiz JR, Goswami D, Lewis KD, Sharmeen AT, Ahmed M, Rahman M, Rahman MZ, Feser J, Neuzil KM, Brooks WA.

Vaccine. 2015 Apr 24. pii: S0264-410X(15)00512-5. doi: 10.1016/j.vaccine.2015.04.048. [Epub ahead of print]

9.

Acute renal failure after influenza vaccination: a case report.

Novati R, Nebiolo PE, Galotto C, Mastaglia M, Manes M.

J Prev Med Hyg. 2014 Mar;55(1):31-2.

PMID:
25916030
10.

Immunogenicity and safety of an AS03-adjuvanted H5N1 pandemic influenza vaccine in Korean adults: A phase IV, randomized, open-label, controlled study.

Izurieta P, Kim WJ, Wie SH, Lee J, Lee JS, Dramé M, Vaughn DW, Schuind A.

Vaccine. 2015 Jun 4;33(24):2800-7. doi: 10.1016/j.vaccine.2015.04.027. Epub 2015 Apr 21.

11.
12.

A single dose of an avian H3N8 vaccine is highly immunogenic and efficacious against a recently emerged seal influenza virus in mice and ferrets.

Baz M, Paskel M, Matsuoka Y, Zengel JR, Cheng X, Treanor JJ, Jin H, Subbarao K.

J Virol. 2015 Apr 22. pii: JVI.00280-15. [Epub ahead of print]

PMID:
25903333
13.

Recommended immunizations for older adults: a primer for pharmacists.

Harte CM, Slattum PW.

Consult Pharm. 2015;30(4):210-20. doi: 10.4140/TCP.n.2015.210.

PMID:
25893699
14.

Impact of health insurance status on vaccination coverage among adult populations.

Lu PJ, O'Halloran A, Williams WW.

Am J Prev Med. 2015 Jun;48(6):647-61. doi: 10.1016/j.amepre.2014.12.008. Epub 2015 Apr 15.

PMID:
25890684
15.

Effectiveness of the 2012/13 trivalent live and inactivated influenza vaccines in children and adolescents in saxony-anhalt, Germany: a test-negative case-control study.

Helmeke C, Gräfe L, Irmscher HM, Gottschalk C, Karagiannis I, Oppermann H.

PLoS One. 2015 Apr 17;10(4):e0122910. doi: 10.1371/journal.pone.0122910. eCollection 2015.

16.

Estimating the potential effects of a vaccine program against an emerging influenza pandemic-United States.

Biggerstaff M, Reed C, Swerdlow DL, Gambhir M, Graitcer S, Finelli L, Borse RH, Rasmussen SA, Meltzer MI, Bridges CB.

Clin Infect Dis. 2015 May 1;60 Suppl 1:S20-9. doi: 10.1093/cid/ciu1175.

PMID:
25878298
17.

[Pneumococcal vaccination for prevention of pneumonia].

Kwetkat A, Hagel S, Forstner C, Pletz MW.

Z Gerontol Geriatr. 2015 Apr 16. [Epub ahead of print] German.

PMID:
25877774
18.

Impact of influenza vaccination on respiratory illness rates in children attending private boarding schools in England, 2013-2014: a cohort study.

Brousseau N, Green HK, Andrews N, Pryse R, Baguelin M, Sunderland A, Ellis J, Pebody R.

Epidemiol Infect. 2015 Apr 16:1-11. [Epub ahead of print]

PMID:
25876454
19.

Vaccines for the prevention of seasonal influenza in patients with diabetes: systematic review and meta-analysis.

Remschmidt C, Wichmann O, Harder T.

BMC Med. 2015 Mar 17;13:53. doi: 10.1186/s12916-015-0295-6.

20.

RSV, an on-going medical dilemma: an expert commentary on RSV prophylactic and therapeutic pharmaceuticals currently in clinical trials.

Broadbent L, Groves H, Shields MD, Power UF.

Influenza Other Respir Viruses. 2015 Apr 3. doi: 10.1111/irv.12313. [Epub ahead of print]

PMID:
25847510
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk